J&J chief admits mistakes at Congressional hearing

October 1, 2010
Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …

Sanofi signs $2.2bn CRO deal

October 1, 2010
Research and Development CRO, Covance, Sanofi-Aventis

Sanofi-Aventis has signed a major deal to contract out a wide range of drug development and laboratory services as part …

The Food and Drug Administration (FDA)

October 1, 2010
FDA, Food and Drug Administration

The current incarnation of the Food and Drug Administration (FDA) was established in 1930, but the US regulator’s modern functions …

National Institute for health and Clinical Excellence (NICE)

October 1, 2010
NICE, National Institute for health and Clinical Excellence

The National Institute for health and Clinical Excellence (NICE) is a UK cost-effectiveness body that assesses a drug’s cost against …

Doctors express serious doubts about health reforms

October 1, 2010
Sales and Marketing BMA, NHS, healthcare reform, reform

The government’s plans for radical reform of the NHS has come under attack from doctors’ association the BMA, which says …

GPs urge more patient ‘self care’ for minor ailments

September 30, 2010
Medical Communications Doctors.net.uk, OTC, doctors, pharma, simon grime

 Research by Doctors.net.uk, on behalf of OTC Bulletin, has revealed that nine out of ten general practitioners in the UK …

Caelyx rights to revert back to Janssen

September 30, 2010
Sales and Marketing Caelyx, Janssen, Merck

Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …

Herceptin packs

New Herceptin data sways NICE

September 30, 2010
Sales and Marketing Herceptin, NICE, Roche

NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …

Termeer exit could help Sanofi

September 30, 2010
Sales and Marketing Genzyme, M&A, MA, Sanofi

Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …

Nestlé to pioneer ‘health science nutrition’

September 29, 2010
Sales and Marketing Alzheimer's, health science nutrition, nestle

Nestlé is to take on conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s with the creation of two research …

EuropeanParliamentWEB

Europe votes for patients’ access to information

September 29, 2010
Medical Communications, Sales and Marketing Europe, medicines information

Members of the European Parliament have voted in favour of giving patients across Europe access to ‘high quality information’ on …

ClinTec recruits former Wyeth VP

September 29, 2010
Research and Development ClinTec, appointment, research and development

Glasgow, UK-based contract research organisation ClinTec has expanded its US operations with the appointment of new executive vice president Dr …

FDA director of manufacturing and product quality Rich Friedman

The FDA Interview: Is pharma getting worse at manufacturing?

September 29, 2010
Manufacturing and Production, Research and Development FDA, manufacturing, manufacturing compliance

It seems that barely a week goes by at the moment without news of another pharmaceutical company falling foul of …

Talking Point: Collaboration required for online activities

September 29, 2010
Medical Communications Red Door, Talking Point, digital

Communicating with customers and patients digitally is top of many people’s agenda at the moment – it’s an exciting area …

Contract research news in brief

September 29, 2010
Research and Development CIT, Cardialysis, PPD, Parexel, Porsolt, Sticares

A round-up of recent news from the CRO sector, featuring updates from CIT, Parexel, PPD, Cardialysis/Sticares and Porsolt. French non-clinical …

Outcomes based measures for Pharma new commercial models

September 29, 2010
Sales and Marketing Kinapse, White paper

It is now widely recognised that Pharma new commercial models will rely on the principles of account management, working collaboratively …

New Commercial Realities Paper Pt 3 – The changing landscape for pharmaceutical commercial operations – roles and organisational scale

September 29, 2010
Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the industry’s traditional commercial models based on …

Pay people to be healthy, say NICE advisors

September 28, 2010
NHS, NICE, public health

The NHS should use financial incentives to encourage people to make healthier lifestyle changes, according to NICE’s Citizen’s Council. The …

Grünenthal breaches Code with off-label promotion

September 28, 2010
Medical Communications Code of Practice, Grunenthal, PMCPA, Versatis

Grünenthal has been severely criticised in two rulings by UK pharma’s self-regulatory body the PMCPA for promoting off-label use of …

Pfizer slims down pipeline

September 28, 2010
Research and Development Pfizer

Pfizer has reduced the number of drugs in its product pipeline as part of a broad refocusing of its R&D …

The Gateway to Local Adoption Series

Latest content